Women’s Health and Breast Profile, Saliva
Orderable by Ontario ND
Test
A comprehensive preventative breast health program extends beyond imaging and lifestyle optimization, and includes assessment and comprehensive treatment of demonstrated hormone imbalances. The Women’s Health and Breast Profile is an accurate, non-invasive tool to advance risk prevention and support you in providing exceptional care to your patients.
Clinical Utility
The Womens Health and Breast Profile includes two risk assessment ratios, the Estrogen Quotient and the Pg/E2 ratio. Dr. Henry Lemon developed the Estrogen Quotient (EQ) which is a simple ratio of the cancer protective E3 to the proliferative estrogens E1 and E2. According to Dr. Lemon, the EQ provides an assessment of breast cancer risk, with a lower number (<1.0) indicating increased risk, and a higher number (>1.0) signifying a lower risk. Dr. Lemons work stated that for maximum protection, an optimal EQ is >1.5. The Pg/E2 ratio, developed by Dr. John Lee, illuminates the relationship between estradiol, which is a proliferative hormone, and progesterone, which balances estradiol and slows cellular proliferation. The information gained from this profile will help to further the conversation with your patients about targeted treatment options such as BHRT, nutraceutical and herbal supplementation, as well as potential lifestyle modifications.
Source:https://www.doctorsdata.com/Womens-Health-and-Breast-Profile
Result Included
- Estradiol (E2)
- Estriol
- Estrone
- Estrogen Quotient
- Progesterone (PG)
- PG/E2 Ratio
- Testosterone
- DHEA
- Cortisol x 4
Test Location
Doctor's Data
Specimen
Specimen Type
Saliva
Collection & Handling
Additional Information
A specimen collection kit is available. To order a kit online, please register or login. For assistance or more information, please click here to send us an email or call 416-422-3000 x 300.
Stability
| Refrigerated | Frozen |
|---|---|
| 10 Days | 21 Days |
Sample Report
Turnaround Time
8 Days
Sample Report
Test Version
Last Updated
2022-05-09